A new drug is being trialled in Devon to slow the progression of type 1 diabetes. Teplizumab, already approved in the US, helps the immune system stop attacking pancreatic cells. This delays the ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

A study led by UCLA has discovered that JAK inhibitors could potentially prevent or reverse immune-related diabetes triggered ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Dr. Victoria Rose spent 21 days in the territory, treating people who were shot trying to get food and children with ...

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising ...

Infections in the brain can have serious consequences and are often fatal. The immune defense system works differently here ...

A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS.

Immune checkpoint inhibitors provide durable clinical responses in multiple difficult-to-treat tumor types. The tumor microenvironment, tumor immunogenicity, antigen presentation, and classic ...